The role of adenosine cyclic monophosphate (c-AMP) in the pathogenesis of epilepsy and the mechanism of the action of anti-epileptic drugs
Szczechowski, L.; Lenart-Grabowska, M.; Marczewska, E.
Wiadomosci Lekarskie 42(13-15): 881-883
1989
ISSN/ISBN: 0043-5147 PMID: 2561312 Document Number: 345729
Modern views on the role of c-AMP and c-CMP in the regulation of metabolism and function of the neuron and synaptic transmission are presented. A hypothesis is put forward of the participation of these cyclic nucleotides in the control of epileptogenic focus through modulation of the resting potential of the neuron.
Document emailed within 1 workday
Related Documents
Szczechowski, L.; Marczewska, E. 1987: Role of membrane receptors in the pathogenesis of epilepsy and in the mechanism of action of anti-epileptic drugs Polski Tygodnik Lekarski 42(16): 485-488Zhikharev, S.S. 1977: Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma Terapevticheskii Arkhiv 49(3): 131-135
Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837
Korostovtseva, D.S.; Kozhemiakin, L.A. 1977: Cyclic adenosine monophosphate system in the pathogenesis of a bronchial asthma attack Voprosy Okhrany Materinstva i Detstva 22(12): 6-9
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Pawlikowski, M.; Lewandowski, J. 1973: Cyclic adenosine-3',5'-monophosphate as the intracellular mediator of hormonal action Endokrynologia Polska 24(2): 105-132
Izumi, F.; Oka, M.; Kashimoto, T. 1971: Possible role of cyclic-3', 5'-adenosine monophosphate in the release of catecholamines from the adrenal medulla Medical Journal of Osaka University 21(4): 241-249
Vollenberger, A.; Kraus, E.G.; Geier, G.; Gents, S. 1972: The behavior and role of cyclic adenosine monophosphate in the myocardium during acute ischemia Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 16(3): 13-16
Osipov, E.V.; Burobin, V.A.; Karelin, A.A. 1976: Role of cyclic adenosine-3',5'-monophosphate in the regulation of histidase in the skin in the process of ontogeny Voprosy Meditsinskoi Khimii 22(2): 203-209
Wirth, J.J.; Kierszenbaum, F. 1982: Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction Journal of Immunology 129(6): 2759-2762
Ganelina, L.S.; Pleskach, V.A.; Rubchenia, A.I.; Ignatova, T.N. 1982: Cyclic adenosine monophosphate and the enzyme activity of its metabolism in L cells sensitive and resistant to the cytotoxic action of ethidium bromide Tsitologiia 24(12): 1393-1397
Reĭzin, F.N.; Roĭkhel', V.M.; Chumakov, M.P. 1975: Effect on drugs changing the intracellular level of adenosine 3',5'-cyclic monophosphate on interferon formation in chick embryo cells of different ages Biulleten' Eksperimental'noi Biologii i Meditsiny 79(6): 49
Yang, Y.; Wang, W.-S.; Qiu, Y.; Sun, L.-H.; Yang, H. 2013: Role of cyclic adenosine monophosphate(cAMP) in the regulation of intestinal epithelial barrier function under hypoxia Zhonghua Wei Chang Wai Ke Za Zhi 16(5): 479-483
Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Fuller, R.W.; Snoddy, H.D.; Bromer, W.W. 1972: Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator Molecular Pharmacology 8(3): 345-352
Cubeddu, L.; Barnes, E.; Weiner, N. 1975: Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate Journal of Pharmacology and Experimental Therapeutics 193(1): 105-127
Georgieva, Z.; Uzunov, P. 1988: The diterpene forskolin--a valuable agent for demonstrating the role of the cyclic 3',5'-adenosine monophosphate system in physiological processes Eksperimentalna Meditsina i Morfologiia 27(1): 56-61
Gamelli, R.L.; He, L.K.; Liu, H.; Ricken, J.D. 1998: Burn wound infection-induced myeloid suppression: the role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate Journal of Trauma 44(3): 469-474